BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
16.35
+0.11 (0.68%)
At close: Aug 13, 2026, 4:00 PM EDT
17.24
+0.89 (5.44%)
After-hours: Aug 13, 2026, 7:39 PM EDT
BlossomHill Therapeutics Market Cap
BlossomHill Therapeutics has a market cap or net worth of $501.02 million as of August 13, 2026.
Market Cap
501.02M
Enterprise Value
408.04M
1-Year Change
n/a
Ranking
Category
Stock Price
$16.35
ChartMarket Cap Chart
Since the IPO on August 7, 2026, BlossomHill Therapeutics's market cap has increased from $465.30M to $501.02M, an increase of 7.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 501.02M | 0.68% |
| Aug 12, 2026 | 497.65M | -1.69% |
| Aug 11, 2026 | 506.23M | 3.31% |
| Aug 10, 2026 | 489.99M | 5.31% |
| Aug 7, 2026 | 465.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 537.57M |
| Ovid Therapeutics | 520.73M |
| Evommune | 520.43M |
| Relmada Therapeutics | 519.48M |
| Adlai Nortye | 507.60M |
| OmniAb | 503.05M |
| C4 Therapeutics | 499.48M |
| Kyverna Therapeutics | 498.77M |